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Abstract
Background: The aim of the present study was to determine whether raised pre-operative serum
creatinine increased the risk of renal failure after liver resection.
Method: Data were studied from 1535 consecutive liver resections. Outcomes in patients with pre-
operative creatinine 124 mmol/l (Group 1) were compared with those with pre-operative creatinine
125 mmol/l (Group 2).
Results: The median age of the 1446 (94.3%) patients resected in Group 1 was 62 years compared with
67 years in the 88 (5.7%) patients in Group 2 (P < 0.0001). Similarly this latter group had double the
number of patients who were American Society of Anesthesiologists (ASA) III or IV (34.1% vs. 15.2%, P
= 0.00004). Overall, the incidence of post-operative renal failure requiring haemofiltration was low (0.9%)
but significantly more in Group 2 patients (5.7% vs. 0.6, P = 0.0007). In addition, patients in Group 2 were
more likely to suffer acute kidney injury post-operatively (18.2% vs. 4.3%, P < 0.0001). Patients with acute
kidney injury had significantly higher blood loss. Although there was no difference in mortality, patients in
Group 2 had higher post-operative morbidity (37.5%) than Group 1 (21.7%, P = 0.0006), with the
incidence of cardiorespiratory complications being higher in Group 2 (25.9% vs. 8.9%, P = 0.0025).
Conclusions: After liver resection, renal failure is rare but patients with an elevated creatinine pre-
operatively are at an increased risk of both renal and non-renal complications.
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Introduction
Twenty years ago, blood loss and subsequent blood transfusion
was recognized as important in the short- and longer-term out-
comes for patients undergoing liver resection and this remains the
case today.1,2 Consequently, surgical and anaesthetic techniques
have evolved in the quest for ‘bloodless surgery’ and now peri-
operative blood transfusion is the exception rather than the rule.3
Two key manoeuvres are used to reduce blood loss during
hepatic transection: portal triad clamping and low central venous
pressure (CVP) anaesthesia. Portal triad clamping, first described
by Pringle in 1908, reduces hepatic arterial and portal venous
bleeding.4,5 Although a recent European survey demonstrated that
the use of inflow occlusion is not universal, it did confirm that
most hepatic surgeons resort to it in difficult cases and that expe-
rienced surgeons are more likely to use it routinely.6 During the
transaction, a low CVP reduces back bleeding from hepatic
veins.7–9 These techniques test the patients’ cardiovascular reserve.
Obstructing the portal blood flow causes venous congestion of the
bowel and in combination with warm ischaemic liver injury,
results in a flush of anaerobic metabolites and cytokines back into
the circulation on release of the clamp.10 Low CVP anaesthesia
relies on patients being maintained in a hypovolaemic state until
liver resection has been completed.7,8 This is in contrast to most
other major surgical procedures, where patients have large
volumes of crystalloid and colloid peri-operatively. Moreover,
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vasodilators are often used to further reduce CVP, leading to dis-
tributive changes in blood flow.7 A potential consequence of such
circulatory changes is acute tubular necrosis (ATN), with subse-
quent renal impairment or failure.11
Studies have shown that 3–7% of patients require renal replace-
ment therapy after liver resection.8,11 The aim of this study was to
determine the outcome of liver resection performed under low
CVP anaesthesia with intermittent inflow occlusion, in patients
with a pre-operative serum creatinine 125 mmol/l (compared
with patients with a serum creatinine124 mmol/l). The primary
endpoint was the requirement for renal replacement therapy as a
consequence of acute kidney injury, with overall peri-operative
morbidity and mortality as secondary endpoints.
Methods
Study design
This was a study of consecutive patients undergoing elective
hepatic resection at a single tertiary referral centre between Feb-
ruary 1991 and August 2008. Patient data were collected prospec-
tively on a database (Access®, Microsoft Corporation, Redmond,
WA, USA) comprising 268 data fields. This was compiled contem-
poraneously using standardized proformas and encompassed
patient symptoms, pre-operative assessment, surgical treatment,
post-operative course, histopathology and long-term outcomes.
Patients operated on prior to February 1991 were excluded, as this
was prior to the introduction of low CVP anaesthesia in our unit.
A single patient who was on long-term renal replacement therapy
was also excluded from the study.
All patients had their urea and electrolytes measured pre-
operatively. The upper limit of the normal reference range for
creatinine in our unit was 124 mmol/l, representing two standard
deviations above the mean. Patients were divided into two groups
depending on their pre-operative serum creatinine: Group 1 –
those with a serum creatinine 124 mmol/l and Group 2 – those
with a serum creatinine 125 mmol/l.
The surgical and anaesthetic techniques used for liver resection
have been previously described by this unit and are used as a
matter of routine.7 During the transection of the hepatic paren-
chyma, low CVP anaesthesia and intermittent portal inflow occlu-
sion were used. The CVP was controlled by balancing judicious
fluid and intravenous nitroglycerine administration against blood
loss, with the aim of mainataing a CVP 0–4 mmHg during
transection. These parameters were usually acheived, without
compromising systemic hypotension. In this event, however, vaso-
pressors (e.g. dopamine, phenylephrine) and fluid boluses were
used to maintain what was considered safe cardiovascular status
by the anaesthetist. Inflow occlusion was typically performed for
20 min, followed by 5 min reperfusion time, and then repeated.
Inflow occlusion was kept to a minimum, ideally less than 60 min
in total.
The nomenclature and extent of hepatic resection were
recorded according to the Brisbane 2000 Terminology of Liver
Anatomy and Resections.12 Major liver resection was defined as
the resection of three or more hepatic segments. A minor resec-
tion was defined as the resection of fewer than three segments,
including wedge resections.
Post-operative care was standardized. All patients had level 2
care for the first 24 h. Patients requiring ventilatory or circulatory
support were admitted to the intensive care unit for level 3 care.
Peri-operative pain relief was provided with either thoracic epi-
dural analgesia or more recently, a regional intermuscular bupiv-
icaine infusion combined with patient controlled-analgesia and
paracetemol.13 Fluid management comprised a background infu-
sion of Gelofusin® (B. Braun, Melsungen, Germany) and 10%
dextrose, with additional boluses of Gelofusin® dictated by urine
output. Patients were allowed to eat and drink from day one as
tolerated. Non-steroidal anti-inflammatory drugs (NSAIDs) were
used routinely for post-operative analgesia in patients once they
were eating, unless they had specific contraindications (allergy,
asthma, peptic ulceration and renal impairment).
Peri-operative mortality was defined as a death during the
same hospital admission or within 90 days of the date of the
operation. Post-operative complications were classified as slight,
relevant (delayed patient discharge) or life threatening (compli-
cations requiring urgent or level 3 care with medical or surgical
intervention).
Glomerular filtration rate (GFR) is now routinely estimated in
some laboratories. The data collected on the patients studied in
this paper largely pre-dates this. Furthermore, patients’ weight
was not recorded, preventing retrospective estimation of GFR.
The patients are therefore considered in two groups, based on
their serum creatinine as stated above. Serum creatinine gives an
approximate guide to glomerular filtration rate and when raised,
is suggestive of renal impairment. Serum creatinine can be
affected by muscle mass and hydration status.14 However, the large
size of the study controls for this type of inherent variation
amongst patients. Post-operative change in serum creatinine was
used to determine the presence or absence of an acute kidney
injury, as defined in a consensus statement from the Acute Kidney
Injury Network.15 Patients were regarded as having acute kidney
injury if the serum creatinine increased by 50% or more, or by
26.4 mmol/l or more above the pre-operative level within 48 h of
surgery. The severity of the injury was staged from I to III, as
detailed in Table 3.
Study outcome measures
The primary outcome measure of this study was post-operative
renal failure necessitating haemofiltration. Secondary outcomes
measured included the development of an acute kidney injury (as
defined above). Intra-operative parameters such as operation time
(taken from induction of anaesthesia to the patient leaving the
operating room at the end of surgery), blood loss, post-operative
morbidity and mortality were also compared.
Statistical analysis
Data were entered on a Statistical Package for the Social Sciences
(version 9) software package (SPSS Inc., Chicago, IL, USA).
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Continuous data was expressed as the median, with the range in
parenthesis. Analysis of categorical data was performed using the
Pearson c2 test or Fisher’s exact test if events were5. Continuous
variables were analysed using the Mann–Whitney U-test.
Results
During the study period, 1535 patients underwent liver resection
in our unit. Of these, 88 (5.7%) had a pre-operative serum crea-
tinine125 mmol/l (Group 2). The patient demographics of both
groups are shown in Table 1. Patients in Group 2 had a higher
median age compared with those in Group 1 (67 years vs. 62 years,
P < 0.0001) and were more likely to be male (89.8% vs. 56.4%,
P < 0.0001). The indication for surgery and the prevalence of
background liver disease were similar in both groups. However,
patients in Group 2 had a significantly higher ASA,16 with
a greater proportion of them being ASA grades 3 and 4 (P =
0.00004).
The magnitude of the liver resection, duration of the surgery
and blood loss was similar in both groups (Table 2). The median
(range) duration of inflow occlusion was 39 (5–104) min in
Group 1, comparable to that of 38 (8–110) min in Group 2 (P =
0.7107). The median length of stay was longer in patients in
Group 2 [9 (4–33) days], compared with the patients in Group 1
[8 (2–97) days], but this failed to reach statistical significance
(P = 0.052).
After liver resection, serum creatinine was measured daily and
patients were stratified according to their pre-operative creatinine
levels (Fig. 1). Patients in Group 2 were arbitrarily subdivided into
those with a pre-operative creatinine between 125 mmol/l and
154 mmol/l (n = 72) and those whose serum creatinine was
155 mmol/l or more (n = 16). Figure 1 shows that there was little
change in serum creatinine in the immediate post-operative
period, even for patients with a pre-operative serum creatinine
between 125 mmol/l and 154 mmol/l. However, in patients with a
pre-operative serum creatinine 155 mmol/l, there was a much
less predictable effect of liver surgery on post-operative serum
creatinine levels, as shown by the wide inter-quartile range in this
group (Fig. 1).
The primary outcome measure of this study was post-operative
renal failure necessitating haemofiltration. Overall, the incidence
of this post-operative complication was extremely low [14/1535
patients (0.9%)] (Table 3). However, a significantly higher per-
centage of patients in Group 2 [5/88 (5.7%)] required haemofil-
tration, compared with those in Group1 [9/1447 (0.6%), P =
0.0007]. Factors considered to have pre-disposed or contributed
to patients developing acute renal failure following surgery are
shown in Table 4. The majority of patients (5 of 9) in Group 1 who
required haemofiltration had a significant peri-operative event.
Three suffered significant blood loss leading to transient hypoten-
sion, one had an air embolus and another a myocardial infarction
that contributed to or precipitated acute renal failure. In contrast,
three out of the five patients in Group 2 that required haemofil-
Table 1 Patient demographic characteristics and operative details
of patients undergoing hepatic resections with a curative intent.
Patients are grouped according to whether they have normal
(124 mmol/l) (Group 1) or elevated (125 mmol/l) (Group 2) pre-
operative serum creatinine
Group 1
n = 1447
Group 2
n = 88
P-value
Median age (range) 62 (21–86) 67 (21–81) <0.0001a
Gender
Male 816 (56.4) 79 (89.8) <0.0001b
Indication for liver resection
Colorectal metastases 1194 (82.5) 75 (85.2) 0.51b
Other neoplasms 207 (14.3) 11 (12.5) 0.63b
Benign disease 46 (3.2) 2 (2.3) 1.0c
Background liver histology
Normal 1138 (78.6) 68 (77.3) 0.76b
Steatotic 252 (17.4) 18 (20.4) 0.56b
Cirrhotic 12 (0.8) 0 (0) 0.47c
Unknown 45 (3.2) 2 (2.3) 1.0c
ASA Score
I and II 1018 (70.4) 48 (54.5) 0.0018b
III and IV 222 (15.3) 30 (34.1) 0.00004b
Unknown 207 (14.2) 10 (11.4) 0.4419b
Major liver resection 880 (60.8) 46 (52.3) 0.112b
aMann-Whitney U-test.
bc2-test.
cFisher's exact Test.
Numbers in parentheses represent percentages unless otherwise stated.
ASA, American Society of Anaesthesia pre-operative assessment
score.16
Table 2 Intra- and post-operative details of patients undergoing hepatic resections with a curative intent. Patients are grouped according to
whether they have normal (124 mmol/l) (Group 1) or elevated (125 mmol/l) (Group 2) pre-operative serum creatinine (median and range)
Risk factors Group 1
n = 1447
Group 2
n = 88
P-value
Duration of surgery (min) 240 (60–730) 260 (90–675) 0.065a
Duration of inflow occlusion (min) 39 (5–104) 38 (8–110) 0.7107a
Blood loss (ml) 350 (10–9998) 372 (10–9252) 0.125a
Length of hospital stay 8 (2–97) 9 (4–33) 0.052a
aMann–Whitney U-test.
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tration underwent an uneventful surgical procedure. One patient
in group 2 was given NSAIDs, contrary to the usual protocol.
Table 3 also shows the number of patients in Groups 1 and 2
who developed an acute kidney injury (Stage I–III) in the imme-
diate post-operative period. It shows that significantly more
patients in Group 2 (18.2%) suffered an acute kidney injury com-
pared with those patients in Group 1 (4.3%, P = 0.0001). The
median blood loss of the patients who developed an acute kidney
injury was significantly higher in both groups [Group 1: 629.5 vs.
330 ml (P < 0.0001), Group 2: 662.5 vs. 372 (P = 0.003)]. Further-
more, the operation time was significantly longer [Group 1: 300
vs. 240 min (P < 0.0001), Group 2: 292.5 vs. 260 min (P = 0.043)].
There was no difference in inflow occlusion times. Acute kidney
injury increased the length of hospital stay in Group 1: 11.5 vs. 8
days (P < 0.0001) but not significantly in Group 2: 10 vs. 9 days
(P = 0.073). None of the patients who required post-operative
haemofiltration required long-term dialysis. Amongst the patients
who required haemofiltration, two out of nine died in Group 1
and one out of five died in Group 2.
Differences in morbidity and mortality were studied as second-
ary outcome measures in the two groups of patients. While there
was no significant difference in mortality between the groups (1.7
vs. 3.4%, P = 0.21), patients in Group 2 had significantly higher
post-operative morbidity (37.5%) compared with those in Group
1 (21.7%, P = 0.0006). Furthermore, they were significantly more
likely to be life threatening (Table 5). There were 397 complica-
tions in 314 patients in Group 1 and 55 complications in 33
patients in Group 2. Thus not only was post-operative morbidity
more common in patients in Group 2, but also these patients were
more likely to experience multiple complications. Figure 2 shows
that there was no difference in the frequency of surgical compli-
cations (e.g. biliary fistula, wound infection), or hepatic insuffi-
ciency between the two groups. However, patients in Group 2 had
a significantly higher incidence of cardiac, respiratory and renal/
urinary tract complications post-operatively.
Discussion
This study shows that the incidence of acute renal failure requiring
renal replacement therapy after liver resection is low (<1%). This
is a testament to modern surgery, anaesthesia and critical care. It
also confirms that the routine use of low CVP anaesthesia and
intermittent inflow occlusion is safe. However, patients with a
pre-operative serum creatinine 125 mmol/l have a 4.3-fold risk
of acute kidney injury and a 9.5-fold risk of requiring haemo-
filtration compared with those with a pre-operative serum
creatinine124 mmol/l. The group of patients who suffered acute
Figure 1 Chart showing the effect of hepatic resection on post-
operative changes in serum creatinine in three patient groups
according to pre-operative serum creatinine (<124, 125-154 and
>155 mmol/l)
The data are shown as the median and inter-quartile range of each
group.
Table 3 The frequency of acute kidney injury in patients undergoing hepatic resection with curative intent. Patients are grouped according
to whether they have normal (124 mmol/l) (Group 1) or elevated (125 mmol/l) (Group 2) pre-operative serum creatinine
N Group 1 Group 2 P-value
1447 88
Acute kidney injury Stage I 50 (3.5) 11 (12.5) 0.0001a
Stage II 9 (0.6) 3 (3.4) 0.0275b
Stage III 3 (0.2) 2 (2.3) 0.0290b
Any stage (Total) 62 (4.3) 16 (18.2) 0.0001a
Patients requiring haemofiltration 9 (0.6) 5 (5.7) 0.0007b
Quantification of acute kidney injury, based on serum creatinine measurements within the first 48 h of surgery.15
Stage I: Cr  1.5–2.0 fold baseline or a rise of 26.4 mmol/l.
Stage II: Cr = 2.0–3.0 fold baseline.
Stage III: Cr > 3.0 fold baseline or 354 mmol/l.
ac2-test.
bFisher's exact test.
Numbers in parentheses represent percentages.
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kidney injury had significantly higher blood loss and operation
time. Furthermore, they have significantly more non-renal com-
plications, particularly respiratory. Although these findings may
be expected, this study provides clear evidence that performing
liver resections in patients with serum creatinine 125 mmol/l is
associated with greater morbidity, where little other evidence
exists. Although patients in group 2 appeared to have a more
complex course, their median hospital stay was not significantly
increased. The data analysed in this study covers a period of 17
years and the median length of hospital stay following uncompli-
cated liver resection has undoubtedly reduced during this period,
in keeping with modern surgical practice. This factor has probably
reduced the observed impact of complications on the length of
hospital stay.
After liver resection, the low rate of renal failure in this series is
the same (0.9%) as another reported series of 5853 patients
undergoing major abdominal surgery and lower than other
reported rates after liver resection (3–7%).8,11,17 The series of
patients studied by Melendez routinely had low CVP anaesthesia
and portal triad clamping. The anaesthetic technique was similar
to that used in our patients, with respect to fluid restriction but
differed in that their patients were positioned 15° head down.
Moreover, in their study nitrates were used when required, rather
than routinely. Saner does not detail their anaesthetic technique.11
There are three main factors which may contribute to the devel-
opment of renal failure after liver resection. Elderly patients and
Table 4 Factors considered to have predisposed or directly contributed to acute renal failure requiring haemofiltration. Patients are grouped
according to whether they have normal (124 mmol/l) (Group 1) or elevated (125 mmol/l) (Group 2) pre-operative serum creatinine
Patient Diabetes IHD/HT Peri-operative event NSAIDs Late sepsis/multi-organ
failure
Group 1 1 ✓
2 Hypotension
3 Hypotension
4 ✓
5 Hypotension
6
7 ✓ ✓ Air Embolus
8 ✓ ✓
9 ✓ ✓ MI
Group 2 1 ✓ ✓
2 ✓
3 ✓
4 ✓
5 ✓ ✓
HT, hypertension; IHD, ischaemic heart disease; MI, myocardial infarction; ✓, predisposing factor present.
Table 5 Post-operative morbidity and mortality of patients undergo-
ing hepatic resections with a curative intent. Patients are grouped
according to whether they have normal (124 mmol/l) (Group 1) or
elevated (125 mmol/l) (Group 2) pre-operative serum creatinine
Post-operative adverse
events
Group 1
n = 1447
Group 2
n = 88
P-value
All complications 314 (21.7) 33 (37.5) 0.0006a
Slight 108 (34.4) 11 (33.3) 0.0863a
Relevant 141 (44.9) 13 (39.4) 0.1275a
Life threatening 65 (20.7) 9 (27.3) 0.0147a
Mortality 25 (1.7) 3 (3.4) 0.2137b
ac2-test.
bFisher's exact test.
Numbers in parentheses represent percentages.
Figure 2 Chart showing the relative frequency of individual compli-
cations between Groups 1 and 2. There were 397 complications in
314 patients in Group 1 (creatinine  124 mmol/l) and 55 complica-
tions in 33 patients in Group 2 (creatinine  125 mmol/l)
*P < 0.05 (c2-test).
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those with conditions such ashypertension, atherosclerosis or
chronic kidney disease are at risk.18 These patients have a reduced
capacity for neurohumeral autoregulation of glomerular blood
flow during surgery and thus an increased risk of ATN.18 Cer-
tainly, the patients in Group 2 were significantly older, with more
comorbidity as indicated by their higher ASA scores, compared
with those in Group 1. Specific co-morbidity was not routinely
recorded in our database; however, it would be of interest to
determine the role of diabetes, hypertension and ischaemic heart
disease in the future. Peri-operative use of NSAIDs may also
impair normal autoregulation of glomerular perfusion through
inhibition arteriolar dilatory prostaglandins.18 In this study, oral
NSAIDs were used routinely for post-operative analgesia once
patients were tolerating diet, but avoided in patients with renal
impairment.
The second factor relates to the ‘hit’ of surgery. Two key players
in the pathogenesis of ATN are hypovolaemia and renal damage
by inflammatory mediators.11 Both these events are predicable in
every hepatic resection that employs low CVP anaesthesia and
portal inflow occlusion. A raised pre-operative serum creatinine
appears to clearly identify the group of patients that are most
susceptible to this surgical ‘hit’.
The third factor which contributes to the aetiology of renal
failure after liver resection is a low perfusion state either secondary
to cardiac dysfunction or distributive circulatory changes, such as
sepsis or hepatorenal failure.11,18 Patients often have more than one
factor contributing to post-operative renal dysfunction. The
potential consequences of acute kidney injury include increased
risk of mortality and may contribute to the development of
chronic kidney disease.15
Despite the differences in age and comorbidity, this study
showed no difference in the rate of surgical complications
between the two groups. Systemic complications accounted for
the higher rates of post-operative morbidity in patients with
raised serum creatinine. However, the relative risk of complica-
tions in this series of patients (1.72) is similar to that previously
observed in patients with a raised serum creatinine in another
large series reported by Jarnagin (1.78).19 In this study of 1803
patients, 59.2% with an elevated serum creatinine suffered post-
operative morbidity, compared with 45.0% with normal serum
creatinine (P = 0.118). When these patients were grouped accord-
ing to those with complications vs. those with no complications,
the group with complications had higher mean serum creatinine
levels (0.92 vs. 0.99 mg/dl). Elevated serum creatinine was also
associated with higher mortality (6.3% vs. 2.9%, P = 0.037). Other
authors have also found that raised pre-operative serum creati-
nine predicts in hospital mortality.20 However, in this Asian series,
a much greater proportion of patients (59.2%) had a background
of chronic liver disease.20
In conclusion, while renal failure following liver resection is
rare, patients with an elevated pre-operative creatinine are at
increased risk of both renal and non-renal complications. Identi-
fication of this high-risk group dictates that level 2 critical care is
mandatory for these patients in the early post-operative period, in
order to optimize fluid balance and cardiac output, while main-
taining a low threshold for haemofiltration. Furthermore, we have
identified a group of patients who need different advice in the
process of obtaining informed consent. This study also reinforces
the need to minimize blood loss in liver surgery. However, the
majority of patients with renal impairment can be offered a major
liver resection with a successful post-operative outcome.
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